| PI: | Lucila Ohno-Machado |
| Co-PIs: | Hoda Anton-Culver (UCI), Atul Butte (UCSF) |
Investigators:
| Amy Sitapati, Elena Martinez, Michael Hogarth, Cinnamon Bloss
|
| Staff: | Rita Kurtz, Victoria Patronilo, Emily Guardado, Akiko Garcia, Karen Bahena, Francesca Lazzaro, Jovan Moreno, Nancy Yuan
|
| Grant: | NIH: OT2OD024611 |
| Start date of Project: | 9/17/2016 |
| Expected duration of Project: | 4/1/2018
|
| Description of Project: | The objective of this initiative is to "engage a million or more Americans to volunteer to contribute their health data to improve health outcomes, fuel the development of new treatments, and catalyze a new era of data-based and more precise medical treatment." Subsequently, the NIH announced the PMI Cohort Program to create a national research cohort (named "All of Us") of one million or more U.S. participants. The California Precision Medicine Consortium (CAPMC) – a partnership among UC Irvine, UC San Diego, UC Davis, UC San Francisco and UC Health, along with Cedars-Sinai Medical Center, the San Diego Blood Bank and the University of Southern California – is one of four regional groups chosen by the National Institutes of Health to take part in a national network of healthcare provider organizations building the Precision Medicine Initiative's research participant group, or cohort. The Precision Medicine Initiative's objective is to create a framework by which medical treatment and prevention can be tailored to each individual. Precision medicine is a groundbreaking health care approach for disease treatment and prevention that takes into account individual differences in lifestyle, environment, and genes to better understand how we can improve and maintain a person's health. |